
Faculty, Staff and Student Publications
Publication Date
8-1-2022
Journal
Matrix Biology
Abstract
Pulmonary hypertension (PH) comprises a diverse group of disorders that share a common pathway of pulmonary vascular remodeling leading to right ventricular failure. Development of anti-remodeling strategies is an emerging frontier in PH therapeutics that requires a greater understanding of the interactions between vascular wall cells and their extracellular matrices. The ubiquitous matrix glycan, hyaluronan (HA), is markedly elevated in lungs from patients and experimental models with PH. Herein, we identified HA synthase-2 (HAS2) in the pulmonary artery smooth muscle cell (PASMC) layer as a predominant locus of HA dysregulation. HA upregulation involves depletion of NUDT21, a master regulator of alternative polyadenylation, resulting in 3'UTR shortening and hyper-expression of HAS2. The ensuing increase of HAS2 and hyper-synthesis of HA promoted bioenergetic dysfunction of PASMC characterized by impaired mitochondrial oxidative capacity and a glycolytic shift. The resulting HA accumulation stimulated pro-remodeling phenotypes such as cell proliferation, migration, apoptosis-resistance, and stimulated pulmonary artery contractility. Transgenic mice, mimicking HAS2 hyper-synthesis in smooth muscle cells, developed spontaneous PH, whereas targeted deletion of HAS2 prevented experimental PH. Pharmacological blockade of HAS2 restored normal bioenergetics in PASMC, ameliorated cell remodeling phenotypes, and reversed experimental PH in vivo. In summary, our results uncover a novel mechanism of HA hyper-synthesis and downstream effects on pulmonary vascular cell metabolism and remodeling.
Keywords
3' Untranslated Regions, Animals, Cell Proliferation, Energy Metabolism, Humans, Hyaluronan Synthases, Hyaluronic Acid, Hypertension, Pulmonary, Mice, Mice, Transgenic, Myocytes, Smooth Muscle, Pulmonary hypertensionVascular, biologyHyaluronanextracellular matrixmetabolismsmooth, muscle cellRNA processing deficiencyhypoxia
DOI
10.1016/j.matbio.2022.06.001
PMID
35671866
PMCID
PMC9676077
PubMedCentral® Posted Date
8-1-2023
PubMedCentral® Full Text Version
Author MSS
Published Open-Access
yes